New, Drug

New Drug Application Approval by the Pharmaceutical Administration Bureau of Macau for Nefecon® for the Treatment of Primary IgA Nephropathy

07.08.2025 - 18:04:49 | prnewswire.co.uk

Calliditas Therapeutics Sweden China

View original content:https://www.prnewswire.co.uk/news-releases/new-drug-application-approval-by-the-pharmaceutical-administration-bureau-of-macau-for-nefecon-for-the-treatment-of-primary-iga-nephropathy-301969929.html

en | FR0006174348 | NEW | boerse | 67979740 |